mi R-34

GPTKB entity

Statements (63)
Predicate Object
gptkbp:instance_of gptkb:RNA_Polymerase
gptkbp:available_at nanoparticles
gptkbp:cause cellular metabolism
cellular interactions
cellular growth
stem cell differentiation
gptkbp:code the MIR34 gene
gptkbp:community immune response
gptkbp:has_role metastasis
https://www.w3.org/2000/01/rdf-schema#label mi R-34
gptkbp:influence drug resistance
gptkbp:initiated_by cancer cell proliferation
gptkbp:interacts_with oncogenes
multiple m RNAs
gptkbp:investigates cardiovascular diseases
gptkbp:is_a_biomarker_for cancer diagnosis
gptkbp:is_a_potential therapeutic target
gptkbp:is_associated_with cellular homeostasis
tumor suppression
tumor progression
therapeutic resistance
response to stress
cancer metastasis
poor prognosis in cancer patients
gptkbp:is_downregulated_in multiple cancers
gptkbp:is_expressed_in various tissues
gptkbp:is_influential_in cellular pathways
cellular response to therapy
gptkbp:is_involved_in gptkb:neurodegenerative_diseases
apoptosis
cellular stress response
inflammation
cancer biology
tumorigenesis
cellular differentiation
neurogenesis
cellular signaling pathways
cellular communication
epigenetic regulation
cellular repair mechanisms
metabolic regulation
cellular signaling networks
gptkbp:is_known_to_modulate cellular apoptosis
gptkbp:is_linked_to cellular senescence
tumor microenvironment
gptkbp:is_part_of mi RNA family
the p53 pathway
gptkbp:is_regulated_by gptkb:p53
gene expression
cellular apoptosis pathways
cellular signaling pathways.
gptkbp:is_studied_for its role in cancer therapy
its potential in regenerative medicine
its role in aging
its role in immune modulation
its role in therapy resistance
gptkbp:is_studied_in clinical trials
therapeutic applications
gptkbp:regulates cell cycle
gptkbp:targets gptkb:SIRT1
gptkb:CDK6
gptkbp:bfsParent gptkb:MDM2
gptkbp:bfsLayer 5